YRHAM
LABU icon

Yong Rong (HK) Asset Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Yong Rong (HK) Asset Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,190
Closed -$260K – 16
2023
Q2 		$260K Buy
+2,190
New +$273K 0.11% 17

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Yong Rong (HK) Asset Management's LABU Position: Q3 2023 in Review

Yong Rong (HK) Asset Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2023, closing a stake of 2,190 shares — an estimated $260K sold.

Yong Rong (HK) Asset Management first reported a position in LABU in Q2 2023 and held it in 1 quarter. The position peaked at $260K in Q2 2023. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2023.

  • Yong Rong (HK) Asset Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2023 after selling out during the quarter.
  • Yong Rong (HK) Asset Management sold 2,190 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2023, an estimated $260K.
  • Yong Rong (HK) Asset Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2023 and held it in 1 quarter.
  • Yong Rong (HK) Asset Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $260K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2023.

Based on Yong Rong (HK) Asset Management's 13F filing for Q3 2023, filed 19 Oct 2023.